AzTrials
AzTrials

AgingCTMNCT05678985

Evaluating Impact and Implementation of Choose to Move (Phase 4)

A study testing Choose to Move in people with Aging and Mobility Limitation, run by University of British Columbia at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objectives of this study are to: 1) evaluate whether Choose to Move (CTM) Phase 4 improves health outcomes in older adults who participate and 2) assess whether CTM Phase 4 is delivered as planned and what factors support or inhibit its delivery at scale. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Aging, Mobility Limitation, Sedentary Behaviour
What is being tested?
Choose to Move
Could I receive a placebo?
No, everyone receives an active treatment
How many people
550 participants
Where
1 siteCanada
Study dates
17 Sep 2020to 29 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ≥60 years of age
  • demonstrate readiness for physical activity via the PAR-Q+ questionnaire, Get Active Questionnaire, or a letter of recommendation from their physician
  • <150 min/week physical activity
  • English speaking
  • Able to connect to the Zoom or GoToMeeting platform via phone or internet in order to participate in virtual group meetings (for online programs only)
  • Activity coaches will be English speaking, British Columbia Recreation and Parks Association (BCRPA) registered older adult fitness leaders or kinesiologists who are delivering CTM at participating centres
Show all 12Show fewer
  • Recreation Managers and Coordinators affiliated with participating centres delivering CTM
  • Provincial Partners (e.g., individuals/partners who make strategic and/or policy decisions) at partner organizations delivering Choose to Move
  • Activity Coach inclusion criteria:
  • Able to connect to the Zoom or GoToMeeting platform via internet (video and audio required in order to see and hear participants) for online programs
  • Able to connect to the Zoom or GoToMeeting platform via phone or internet in order to participate in virtual group meetings (for online programs only)
  • Currently (or recently completed) participating in CTM evaluation

Who cannot join

  • Previous participation in CTM

Trial locations and contacts

1 site in 1 country.

Canada1 site

  • Centre for Hip Health and Mobility, Robert H.N. Ho Research Centre, University of British Columbia

    Vancouver, British Columbia, V5Z 1M9

Other trials in Canada

About this study

Official title: Choose to Move (Phase 4): Impact and Implementation Evaluation of a Program to Enhance Older Adult Physical Activity, Mobility and Health

The objectives of this study are to: 1) evaluate whether Choose to Move (CTM) Phase 4 improves health outcomes in older adults who participate and 2) assess whether CTM Phase 4 is delivered as planned and what factors support or inhibit its delivery at scale.

CTM Phase 4 is a 3-month, choice-based program for low active older adults being scaled-up across British Columbia (BC), Canada. The goals of CTM are to enhance physical activity, mobility and social connectedness in older adults living in BC, Canada.

Read the detailed description

Choose to Move (CTM) Phase 4 is a 3-month, choice-based program for low active older adults being scaled-up in phases across British Columbia (BC), Canada. Within CTM (Phase 4), trained activity coaches support older adults in two ways. First, in a one-on-one consultation, activity coaches help participants to set goals and create action plans for physical activity tailored to each person's interests and abilities. Older adults can choose to participate in individual or group-based activities. Second, activity coaches facilitate 8 group meetings with small groups of participants. Activity coaches and recreation departments across BC are trained and provided with resources to deliver CTM.

Objectives:

  1. To assess the impact (effectiveness) of CTM (Phase 4) delivered at scale on the physical activity, mobility, and social connectedness of older adults (Part I - Impact Evaluation)
  2. To assess whether CTM (Phase 4) was implemented as planned (fidelity) and investigate factors that support or inhibit its implementation at scale (Part II - Implementation Evaluation).

Study Design:

The investigators use a hybrid type 2 effectiveness-implementation (Curran et al 2012) pre-post study design to evaluate CTM. The investigators use multiple methods (quantitative and qualitative) and collect data at 0 (baseline), 3 (post-intervention), 6 (3 months post-intervention), 15 (12 months post-intervention) and 27 (24 months post-intervention) months to assess impact and implementation of CTM.

Being tested
Choose to Move
Keywords
Older adults, Behaviour change, Physical inactivity, Mobility, Social connectedness, Loneliness, Effectiveness, Maintenance, Implementation, Adaptation, Acceptability, Feasibility, Fidelity, Dose
Medical subject headings
Mobility Limitation, Social Isolation, Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Choose to MoveBehavioural

    As described under study arm description.

Study groups in NCT05678985
Study groupRoleWhat they receive
Choose to MoveExperimentalCTM (Phase 4) is a 3-month, flexible, choice-based program for low active older adults that can be delivered in-person or online. CTM includes * One-on-One Consultation: Participants meet 1-on-1 with their activity coach at the start of the program to set goals and develop an action plan tailored to their abilities, interests and resources. Older adults can choose to participate in individual or group-based activities. * Group Meetings: Over the 3-months, participants will attend eight, 1-hour group-based meetings (up to 12 participants total) led by their activity coach. Meetings cover a discussion topic (health-related) and provide time and space for social connection between participants. Group meetings are held in person or online as public health restrictions and community preference dictate.
Receives: Behavioral: Choose to Move

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in physical activity

    The single item physical activity questionnaire will be used to measure physical activity. Output variable is self-reported number of days/week ≥30 min physical activity in the past week (range 0-7).

    Measured: 0, 3, 6, 15, 27-months

Secondary outcomes (12)

  1. Change in capacity for mobility

    Two items will assess participants' ability to walk a quarter of a mile and up 10 steps. The output variable is self-reported presence of mobility-disability (no/any difficulty walking 400m or climbing one flight of stairs).

    Measured: 0, 3, 6, 15, 27-months

  2. Change in physical functioning

    The Physical Functioning Subscale of the SF-36 will be used to assess the physical function aspect of mobility. The measure asks participants to rate if their health limits them in performing 10 different activities. The output variable is an average score (range 0-100) of physical functioning, where a higher score indicates a more favourable health state.

    Measured: 0, 3, 6, 15, 27-months

  3. Change in mobility

    The Mobility Assessment Tool-Short Form (MAT-sf) will be used to assess mobility. MAT-sf is a validated, short form video-animated tool to assess participant self-perception of mobility. Only participants with an internet connection are able to complete this measure. The output variable is a self-perception of mobility score (range 23.45-67.61) where a higher score indicates greater perceived mobility.

    Measured: 0, 3, 6, 15, 27-months

  4. Change in loneliness

    The three-item loneliness scale will be used to assess loneliness. Participants rate three aspects of loneliness. The output variable is loneliness score (range 3-9); lower scores indicate lower levels of loneliness.

    Measured: 0, 3, 6, 15, 27-months

  5. Change in social isolation

    A three-item questionnaire adapted from two questions on social contact frequency will be used to assess social isolation. The output variable is social isolation score (range 0-15); higher scores indicate lower levels of social isolation.

    Measured: 0, 3, 6, 15, 27-months

  6. Change in social network

    A six-item questionnaire will be used to assess social network. The output variable is an equally weighted sum (range 0-30) where higher scores indicate more social engagement.

    Measured: 0, 3, 6, 15, 27-months

  7. Change in social connectedness

    A single item will be used to assess sense of belonging as an indicator of social connectedness. The output variable is sense of belonging score (range 1-4) where lower scores indicate a stronger sense of belonging.

    Measured: 0, 3, 6, 15, 27-months

  8. Change in sitting time

    A five-item questionnaire will be used to assess change in sitting time (hours and minutes) each day in the following domains: (a) while travelling to and from places (e.g., work, shops); (b) while at work; (c) while watching television; (d) while using a computer at home; and (e) at leisure not including watching television (e.g., visiting friends, movies, eating out) on a weekday and a weekend day. The output variables are sitting hours per day across 5 domains.

    Measured: 0, 3, 6, 15, 27-months

  9. Change in screen time

    A single item will be used to assess screen time. The output variable is hours of screen time per day.

    Measured: 0, 3, 6, 15, 27-months

  10. Change in health-related quality of life (EQ-5D-5L Profile)

    Health status will be assessed using the EQ-5D-5L. Participants report on mobility, self-care, usual activities, pain/discomfort and anxiety/depression on a scale from 1-5 (level of perceived problems) for each item. Responses are used to create a 5-digit number which will be used descriptively (11111 indicates no problems on any of the five dimensions whereas 55555 indicates extreme problems on all five dimensions).

    Measured: 0, 3, 6, 15, 27-months

  11. Change in health-related quality of life (EQ-5D-5L Level Sum Score)

    Health status (EQ-5D-5L Level Sum Score) will be assessed with the EQ-5D-5L. Participants report on mobility, self-care, usual activities, pain/discomfort and anxiety/depression on a scale from 1-5 (level of perceived problems) for each item. The Level Sum Score uses the 5-digit profile to create a numeric score, with scores ranging from 5-25 (lower levels indicate lower levels of perceived problems).

    Measured: 0, 3, 6, 15, 27-months

  12. Change in health-related quality of life (EQ-5D-5L Visual Analogue Scale)

    Health status will be assessed with the EQ-5D-5L visual analogue scale. Participants report on their health on a visual analogue scale from 0 (worst health) to 100 (best health).

    Measured: 0, 3, 6, 15, 27-months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2023
  2. Study start17 Sep 2020
  3. Primary completion29 Jan 2025
  4. Study completion29 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
550 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05678985
Sponsor's protocol ID
H20-00780
Other IDs
PJT-169159
Acronym
CTM
Status last verified
Mar 2025
First submitted
19 Dec 2022
Last updated
27 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.

    PubMed 22310560

  • Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT. A Short Scale for Measuring Loneliness in Large Surveys: Results From Two Population-Based Studies. Res Aging. 2004;26(6):655-672. doi: 10.1177/0164027504268574.

    PubMed 18504506

  • Lau, E. Y., Wandersman, A.H., & Pate, R. R. Factors Influencing Implementation of Youth Physical Activity Interventions: An Expert Perspective. Translational Journal of the ACSM: July 1, 2016 - Volume 1 - Issue 7 - p 60-70 doi: 10.1249/TJX.0000000000000006

  • Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, Stuck AE. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist. 2006 Aug;46(4):503-13. doi: 10.1093/geront/46.4.503.

    PubMed 16921004

  • Marshall AL, Miller YD, Burton NW, Brown WJ. Measuring total and domain-specific sitting: a study of reliability and validity. Med Sci Sports Exerc. 2010 Jun;42(6):1094-102. doi: 10.1249/MSS.0b013e3181c5ec18.

    PubMed 19997030

  • Rejeski WJ, Rushing J, Guralnik JM, Ip EH, King AC, Manini TM, Marsh AP, McDermott MM, Fielding RA, Newman AB, Tudor-Locke C, Gill TM; LIFE Study Group. The MAT-sf: identifying risk for major mobility disability. J Gerontol A Biol Sci Med Sci. 2015 May;70(5):641-6. doi: 10.1093/gerona/glv003. Epub 2015 Feb 13.

    PubMed 25680917

  • Simonsick EM, Newman AB, Visser M, Goodpaster B, Kritchevsky SB, Rubin S, Nevitt MC, Harris TB; Health, Aging and Body Composition Study. Mobility limitation in self-described well-functioning older adults: importance of endurance walk testing. J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):841-7. doi: 10.1093/gerona/63.8.841.

    PubMed 18772472

  • EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.

    PubMed 10109801

  • Veroff, J., Kulka, R. A., & Douvan, E. A. M. (1981). Mental health in America: patterns of help-seeking from, 1957 to 1976: patterns of help-seeking from 1957 to 1976. Basic Books.

  • Warburton, D. E., Jamnik, V. K., Bredin, S. S., & Gledhill, N. (2011). The physical activity readiness questionnaire for everyone (PAR-Q+) and electronic physical activity readiness medical examination (ePARmed-X+). The Health & Fitness Journal of Canada, 4(2), 3-17.

  • Ware, J. E. (1989). SF-36 health status questionnaire. Boston, MA: Institute for the Improvement of Medical Care and Health, New England Medical Center Hospital, Quality Quest Inc.

  • Milton K, Bull FC, Bauman A. Reliability and validity testing of a single-item physical activity measure. Br J Sports Med. 2011 Mar;45(3):203-8. doi: 10.1136/bjsm.2009.068395. Epub 2010 May 19.

    PubMed 20484314

  • Holt, D.T., Armenakis, A.A., Feild, H.S., & Harris, S.G. Readiness for Organizational Change: the systematic development of a scale. The Journal of Applied Behavioral Science. 2007; 43(2): 232-255. https://doi.org/10.1177/0021886306295295

  • Vancouver Coastal Health, Fraser Health, University of British Columbia. My Health My Community Survey. 2014. https://myhealthmycommunity.org/

  • Szewczyk Z, Macdonald HM, Pinheiro MB, Nettlefold L, Sims Gould J, McKay HA. Are costs optimized as scale-up of Choose to Move-an effective health-promoting intervention for older adults-proceeds? Int J Behav Nutr Phys Act. 2025 Nov 13;22(1):144. doi: 10.1186/s12966-025-01826-4.

    PubMed 41233872

Questions about this trial

What is this clinical trial studying?

A study testing Choose to Move in people with Aging and Mobility Limitation, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in physical activity (time frame: 0, 3, 6, 15, 27-months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05678985, which also lists 17 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in